Stock Information
Precigen Inc (PGEN)
Ticker Symbol: PGEN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,661.99 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -0.52
Revenue (TTM): $0.21 M
Dividend Yield: N/A
ROE: -498.32%
Latest News
-
Vertex Posts Positive Phase II Data on Kidney Disease Drug
Wed, Sep 23, 2026 4:08 PM
-
AstraZeneca's Trixeo Secures Approval for Asthma in the EU
Wed, Sep 23, 2026 3:00 PM
-
AMGN's Dazodalibep Meets Goal in Systemic Sjogren's Disease Study
Wed, Sep 23, 2026 2:38 PM
-
FDA Accepts Insmed's Filing Seeking Label Expansion for Arikayce
Tue, Sep 22, 2026 4:23 PM
-
AbbVie's Rinvoq Wins EU Approval in Juvenile Idiopathic Arthritis
Tue, Sep 22, 2026 4:17 PM
-
Alkermes Posts Positive Data From Phase I ADHD Study on ALKS 7290
Tue, Sep 22, 2026 3:15 PM
-
JNJ's Caplyta Shows Benefit in Bipolar 1 Related Mania Study
Tue, Sep 22, 2026 3:13 PM
-
AZN's Klygefa Gets CHMP Nod for Generalised Myasthenia Gravis in EU
Mon, Sep 21, 2026 5:29 PM
-
Merck Gets CHMP Backing for Keytruda-Padcev Combo in Bladder Cancer
Mon, Sep 21, 2026 3:27 PM
-
CHMP Backs CORT's Lifyorli Combo in Platinum-Resistant Ovarian Cancer
Mon, Sep 21, 2026 3:07 PM
Key Financials
Financial data not available
